JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 14, 2007, 10.2967/jnumed.107.041574
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.041574v1
48/10/1662    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inglese, E.
Right arrow Articles by Sambuceti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inglese, E.
Right arrow Articles by Sambuceti, G.
Journal of Nuclear Medicine Vol. 48 No. 10 1662-1669
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.041574

Clinical Investigation

Spatial and Temporal Heterogeneity of Regional Myocardial Uptake in Patients Without Heart Disease Under Fasting Conditions on Repeated Whole-Body 18F-FDG PET/CT

Eugenio Inglese1, Lucia Leva1, Roberta Matheoud2, Gianmauro Sacchetti1, Chiara Secco2, Patrizia Gandolfo3, Marco Brambilla2 and Gianmario Sambuceti3

1 Nuclear Medicine Department, University of Eastern Piedmont, Azienda Ospedaliera Maggiore della Carità, Novara, Italy; 2 Medical Physics Department, Azienda Ospedaliera Maggiore della Carità, Novara, Italy; and 3 Nuclear Medicine Department, University of Genoa, Ospedale San Martino, Genova, Italy

Correspondence: For correspondence or reprints contact: Marco Brambilla, PhD, Medical Physics Department, A.O. Maggiore della Carità, C.so Mazzini 18, 28100 Novara, Italy. E-mail: marco.brambilla{at}maggioreosp.novara.it

Imaging of cardiac 18F-FDG uptake is used in the diagnostic evaluation of residual viable myocardium. Although, originally, hibernating myocardium was identified by a mismatch between perfusion defect and relatively preserved 18F-FDG uptake, at present several studies propose that 18F-FDG distribution can also be used alone for this purpose. Nevertheless, even severe myocardial 18F-FDG uptake defects are frequently observed in cancer patients without any cardiac disease. The aim of this study was to retrospectively analyze global and regional 18F-FDG cardiac images of 49 consecutive cancer patients free of cardiac diseases who submitted to 3 PET scans under fasting conditions. Methods: Images were acquired with a high-resolution PET/CT scanner. Three-dimensional regions of interest were drawn on the fused PET/CT images to measure the maximal standardized uptake value of the left ventricular myocardium (SUVMyo) as well as the average SUV of the left ventricular blood (SUVLV) and of the liver (SUVLiver). Analysis of regional myocardial 18F-FDG uptake was performed on a subsample of 26 patients by an automatic recognition of endocardial and epicardial borders and subdividing the left ventricle in 20 segments. Regional 18F-FDG distribution was defined as the percentage of SUVMyo in each region. Results: SUVMyo as well as SUVLV and SUVLiver did not change on average throughout the studies. This stability was not caused by a persistent pattern of myocardial 18-FDG distribution. Rather, it was associated with important variations in both directions over time. Regional 18F-FDG distribution was largely heterogeneous in all 3 studies, with a variation coefficient in each patient of 18% ± 7%, 18% ± 5%, and 17% ± 5%, respectively. An 18F-FDG uptake of <50% occurred in 78, 102, and 69 of 468 segments, although it disappeared in 55% of instances at subsequent examinations. Regional temporal variability was also marked: The absolute value of the difference in percent uptake was 10.1% ± 7.3% from test 1 to test 2, 8.0% ± 7.0% from test 1 to test 3, and 9.2% ± 6.9% from test 2 to test 3. Overall from one test to another, uptake increased or decreased by >10% in 76 and in 116 of 468 segments, respectively. Conclusion: The large spatial and temporal heterogeneity of the myocardial metabolic pattern, in cancer patients free of any disease, suggests a word of caution on the use of 18F-FDG alone as a diagnostic tool for myocardial viability.

Key Words: 18F-FDG • whole-body PET/CT • cardiac uptake

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
NEJMHome page
J. A. Timmons, B. K. Pedersen, N. Stefan, C. Pfannenberg, H.-U. Haring, F. Villarroya, P. Domingo, M. Giralt, H. A. Jacene, R. L. Wahl, et al.
The Importance of Brown Adipose Tissue
N. Engl. J. Med., July 23, 2009; 361(4): 415 - 421.
[Full Text] [PDF]


Home page
JNMHome page
K. Zophel and J. Kotzerke
High Intraindividual Variability of Global Myocardial 18F-FDG Uptake over Time
J. Nucl. Med., September 1, 2008; 49(9): 1570 - 1570.
[Full Text] [PDF]


Home page
JNMHome page
E. Inglese, L. Leva, R. Matheoud, G. Sacchetti, C. Secco, M. Brambilla, P. Gandolfo, and G. Sambuceti
Reply: High Intraindividual Variability of Global Myocardial 18F-FDG Uptake over Time
J. Nucl. Med., September 1, 2008; 49(9): 1570 - 1571.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.